D
Nephros, Inc.
NEPH
$1.62
-$0.04-2.41%
D
Sell
1/6/2025Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 1/6/2025 due to a noticeable increase in the growth index, volatility index and solvency index. EBIT increased 164.98% from -$317 to $206, earnings per share increased from -$0.0275 to $0.0174, and the quick ratio increased from 2.54 to 3.92.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 1/6/2025 due to a noticeable increase in the growth index, volatility index and solvency index. EBIT increased 164.98% from -$317 to $206, earnings per share increased from -$0.0275 to $0.0174, and the quick ratio increased from 2.54 to 3.92.
E
Sell
10/10/2024Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 10/10/2024 due to a decline in the volatility index and total return index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 10/10/2024 due to a decline in the volatility index and total return index.
D
Sell
9/25/2024Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 9/25/2024 due to an increase in the volatility index and valuation index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 9/25/2024 due to an increase in the volatility index and valuation index.
E
Sell
9/5/2024Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index.
D
Sell
8/16/2024Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 8/16/2024 due to an increase in the total return index and volatility index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 8/16/2024 due to an increase in the total return index and volatility index.
E
Sell
7/24/2024Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 7/24/2024 due to a decline in the volatility index and valuation index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 7/24/2024 due to a decline in the volatility index and valuation index.
D
Sell
7/8/2024Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 7/8/2024 due to an increase in the volatility index and total return index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 7/8/2024 due to an increase in the volatility index and total return index.
E
Sell
6/20/2024Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 6/20/2024 due to a decline in the volatility index and total return index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 6/20/2024 due to a decline in the volatility index and total return index.
D
Sell
6/5/2024Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 6/5/2024 due to a significant increase in the growth index and volatility index. EBIT increased 69.18% from -$649 to -$200, earnings per share increased from -$0.0624 to -$0.02, and total revenue increased 8.24% from $3.25M to $3.52M.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 6/5/2024 due to a significant increase in the growth index and volatility index. EBIT increased 69.18% from -$649 to -$200, earnings per share increased from -$0.0624 to -$0.02, and total revenue increased 8.24% from $3.25M to $3.52M.
E
Sell
5/24/2024Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 5/24/2024 due to a substantial decline in the growth index, volatility index and valuation index. EBIT declined 219.7% from -$203 to -$649, earnings per share declined from -$0.02 to -$0.0624, and operating cash flow declined 142.17% from $562 to -$237.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 5/24/2024 due to a substantial decline in the growth index, volatility index and valuation index. EBIT declined 219.7% from -$203 to -$649, earnings per share declined from -$0.02 to -$0.0624, and operating cash flow declined 142.17% from $562 to -$237.
D
Sell
12/4/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 12/4/2023 due to an increase in the volatility index and total return index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 12/4/2023 due to an increase in the volatility index and total return index.
E
Sell
11/17/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 11/17/2023 due to a decline in the volatility index and valuation index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 11/17/2023 due to a decline in the volatility index and valuation index.
D
Sell
11/13/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 11/13/2023 due to an increase in the volatility index and total return index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 11/13/2023 due to an increase in the volatility index and total return index.
E
Sell
10/27/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 10/27/2023 due to a decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 10/27/2023 due to a decline in the volatility index.
D
Sell
10/9/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 10/9/2023 due to an increase in the volatility index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 10/9/2023 due to an increase in the volatility index.
E
Sell
9/21/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 9/21/2023 due to a decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 9/21/2023 due to a decline in the volatility index.
D
Sell
9/1/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 9/1/2023 due to an increase in the total return index and volatility index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 9/1/2023 due to an increase in the total return index and volatility index.
E
Sell
8/16/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 8/16/2023 due to a noticeable decline in the growth index, volatility index and solvency index. EBIT declined 42.16% from -$306 to -$435, earnings per share declined from -$0.0297 to -$0.042, and operating cash flow declined 18.12% from $276 to $226.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 8/16/2023 due to a noticeable decline in the growth index, volatility index and solvency index. EBIT declined 42.16% from -$306 to -$435, earnings per share declined from -$0.0297 to -$0.042, and operating cash flow declined 18.12% from $276 to $226.
D
Sell
8/11/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 8/11/2023 due to an increase in the volatility index and growth index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 8/11/2023 due to an increase in the volatility index and growth index.
E
Sell
7/26/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index.
D
Sell
7/7/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 7/7/2023 due to an increase in the volatility index and total return index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 7/7/2023 due to an increase in the volatility index and total return index.
E
Sell
6/21/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index and valuation index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index and valuation index.
D
Sell
5/31/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 5/31/2023 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 241.54% from -$195 to $276, earnings per share increased from -$0.0887 to -$0.0297, and EBIT increased 55.84% from -$693 to -$306.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 5/31/2023 due to a major increase in the growth index, volatility index and solvency index. Operating cash flow increased 241.54% from -$195 to $276, earnings per share increased from -$0.0887 to -$0.0297, and EBIT increased 55.84% from -$693 to -$306.
E
Sell
3/14/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
11/21/2022Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/21/2022 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.1168 to -$0.3136, total revenue declined 16.47% from $2.88M to $2.41M, and EBIT declined 6.4% from -$1.2M to -$1.28M.
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/21/2022 due to a large decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.1168 to -$0.3136, total revenue declined 16.47% from $2.88M to $2.41M, and EBIT declined 6.4% from -$1.2M to -$1.28M.
D
Sell
8/17/2022Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/17/2022 due to a noticeable increase in the growth index. Earnings per share increased from -$0.1987 to -$0.1168, operating cash flow increased 40.35% from -$1.8M to -$1.07M, and EBIT increased 38.35% from -$1.95M to -$1.2M.
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/17/2022 due to a noticeable increase in the growth index. Earnings per share increased from -$0.1987 to -$0.1168, operating cash flow increased 40.35% from -$1.8M to -$1.07M, and EBIT increased 38.35% from -$1.95M to -$1.2M.
D
Sell
6/16/2022Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 6/16/2022 due to a decline in the total return index and volatility index.
Nephros, Inc. (NEPH) was downgraded to D- from D on 6/16/2022 due to a decline in the total return index and volatility index.
D
Sell
6/1/2022Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 6/1/2022 due to an increase in the valuation index.
Nephros, Inc. (NEPH) was upgraded to D from D- on 6/1/2022 due to an increase in the valuation index.
D
Sell
5/13/2022Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 5/13/2022 due to a significant decline in the growth index, solvency index and total return index. Operating cash flow declined 436.42% from -$335 to -$1.8M, EBIT declined 88.15% from -$1.04M to -$1.95M, and earnings per share declined from -$0.1082 to -$0.1987.
Nephros, Inc. (NEPH) was downgraded to D- from D on 5/13/2022 due to a significant decline in the growth index, solvency index and total return index. Operating cash flow declined 436.42% from -$335 to -$1.8M, EBIT declined 88.15% from -$1.04M to -$1.95M, and earnings per share declined from -$0.1082 to -$0.1987.
D
Sell
5/4/2022Upgraded
Nephros, Inc. (NEPH) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
Nephros, Inc. (NEPH) was upgraded to D from E+ on 5/4/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Nephros, Inc. (NEPH) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Nephros, Inc. (NEPH) was upgraded to D from E+ on 04/21/2022.
Nephros, Inc. (NEPH) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.88 to 3.6.
Nephros, Inc. (NEPH) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.88 to 3.6.
D
Sell
11/23/2021Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/23/2021.
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and total return index. Net income declined 3.04% from -$1.19M to -$1.22M.
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/8/2021 due to a decline in the efficiency index and total return index. Net income declined 3.04% from -$1.19M to -$1.22M.
D
Sell
2/28/2020Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 2/28/2020 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 159.28% from -$614 to $364, earnings per share increased from -$0.1044 to -$0.0258, and net income increased 74.5% from -$804 to -$205.
Nephros, Inc. (NEPH) was upgraded to D from D- on 2/28/2020 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 159.28% from -$614 to $364, earnings per share increased from -$0.1044 to -$0.0258, and net income increased 74.5% from -$804 to -$205.
D
Sell
12/12/2019Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 12/12/2019 due to a decline in the valuation index.
Nephros, Inc. (NEPH) was downgraded to D- from D on 12/12/2019 due to a decline in the valuation index.
D
Sell
11/27/2019Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/27/2019 due to an increase in the valuation index.
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/27/2019 due to an increase in the valuation index.
D
Sell
11/12/2019Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/12/2019 due to a decline in the valuation index, growth index and solvency index.
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/12/2019 due to a decline in the valuation index, growth index and solvency index.
D
Sell
11/6/2019Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/6/2019 due to an increase in the total return index and volatility index.
Nephros, Inc. (NEPH) was upgraded to D from D- on 11/6/2019 due to an increase in the total return index and volatility index.
D
Sell
9/30/2019Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 9/30/2019 due to a decline in the valuation index.
Nephros, Inc. (NEPH) was downgraded to D- from D on 9/30/2019 due to a decline in the valuation index.
D
Sell
8/19/2019Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/19/2019 due to a noticeable increase in the total return index, growth index and valuation index. EBIT increased 33.1% from -$1.31M to -$877, earnings per share increased from -$0.1975 to -$0.1358, and total revenue increased 30.53% from $1.77M to $2.31M.
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/19/2019 due to a noticeable increase in the total return index, growth index and valuation index. EBIT increased 33.1% from -$1.31M to -$877, earnings per share increased from -$0.1975 to -$0.1358, and total revenue increased 30.53% from $1.77M to $2.31M.
D
Sell
3/13/2019Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D+ on 3/13/2019 due to a significant decline in the growth index, efficiency index and total return index. Earnings per share declined from -$0.0088 to -$0.0159, EBIT declined 42.66% from -$511 to -$729, and net income declined 14.49% from -$566 to -$648.
Nephros, Inc. (NEPH) was downgraded to D- from D+ on 3/13/2019 due to a significant decline in the growth index, efficiency index and total return index. Earnings per share declined from -$0.0088 to -$0.0159, EBIT declined 42.66% from -$511 to -$729, and net income declined 14.49% from -$566 to -$648.
D
Sell
11/14/2018Upgraded
Nephros, Inc. (NEPH) was upgraded to D+ from D on 11/14/2018 due to an increase in the growth index, efficiency index and solvency index. The quick ratio increased from 3.13 to 4.76, total capital increased 43.69% from $5.79M to $8.32M, and total revenue increased 26.21% from $1.37M to $1.72M.
Nephros, Inc. (NEPH) was upgraded to D+ from D on 11/14/2018 due to an increase in the growth index, efficiency index and solvency index. The quick ratio increased from 3.13 to 4.76, total capital increased 43.69% from $5.79M to $8.32M, and total revenue increased 26.21% from $1.37M to $1.72M.
D
Sell
8/14/2018Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/14/2018 due to a large increase in the growth index, total return index and solvency index. The quick ratio increased from 1.46 to 3.13, debt to equity declined from 0.7 to 0.29, and earnings per share increased from -$0.0257 to -$0.0109.
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/14/2018 due to a large increase in the growth index, total return index and solvency index. The quick ratio increased from 1.46 to 3.13, debt to equity declined from 0.7 to 0.29, and earnings per share increased from -$0.0257 to -$0.0109.
D
Sell
5/10/2018Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 5/10/2018 due to a substantial decline in the growth index, efficiency index and solvency index. Earnings per share declined from $0.0237 to -$0.03, net income declined 210.86% from $1.29M to -$1.43M, and EBIT declined 178.66% from -$403 to -$1.12M.
Nephros, Inc. (NEPH) was downgraded to D- from D on 5/10/2018 due to a substantial decline in the growth index, efficiency index and solvency index. Earnings per share declined from $0.0237 to -$0.03, net income declined 210.86% from $1.29M to -$1.43M, and EBIT declined 178.66% from -$403 to -$1.12M.
D
Sell
2/27/2018Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 2/27/2018 due to a major increase in the total return index, growth index and volatility index. Operating cash flow increased 351.61% from -$713 to $1.79M, earnings per share increased from -$0.0117 to $0.0191, and total revenue increased 41.92% from $916 to $1.3M.
Nephros, Inc. (NEPH) was upgraded to D from D- on 2/27/2018 due to a major increase in the total return index, growth index and volatility index. Operating cash flow increased 351.61% from -$713 to $1.79M, earnings per share increased from -$0.0117 to $0.0191, and total revenue increased 41.92% from $916 to $1.3M.
D
Sell
11/11/2016Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/11/2016 due to a decline in the efficiency index, solvency index and volatility index. Debt to equity increased from 0.47 to 0.67, and total capital declined 17.57% from $2.46M to $2.03M.
Nephros, Inc. (NEPH) was downgraded to D- from D on 11/11/2016 due to a decline in the efficiency index, solvency index and volatility index. Debt to equity increased from 0.47 to 0.67, and total capital declined 17.57% from $2.46M to $2.03M.
D
Sell
8/12/2016Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/12/2016 due to an increase in the volatility index, efficiency index and total return index. Net income increased 0.12% from -$836 to -$835.
Nephros, Inc. (NEPH) was upgraded to D from D- on 8/12/2016 due to an increase in the volatility index, efficiency index and total return index. Net income increased 0.12% from -$836 to -$835.
D
Sell
5/12/2016Upgraded
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 5/12/2016 due to a noticeable increase in the growth index, efficiency index and solvency index. Operating cash flow increased 57.9% from -$1.24M to -$522, earnings per share increased from -$0.0224 to -$0.0174, and total revenue increased 15.46% from $511 to $590.
Nephros, Inc. (NEPH) was upgraded to D- from E+ on 5/12/2016 due to a noticeable increase in the growth index, efficiency index and solvency index. Operating cash flow increased 57.9% from -$1.24M to -$522, earnings per share increased from -$0.0224 to -$0.0174, and total revenue increased 15.46% from $511 to $590.
E
Sell
3/31/2016Downgrade
Nephros, Inc. (NEPH) was downgraded to E+ from D on 3/31/2016 due to a decline in the valuation index and volatility index.
Nephros, Inc. (NEPH) was downgraded to E+ from D on 3/31/2016 due to a decline in the valuation index and volatility index.
D
Sell
3/29/2016Upgraded
Nephros, Inc. (NEPH) was upgraded to D from D- on 3/29/2016 due to an increase in the valuation index, total return index and volatility index.
Nephros, Inc. (NEPH) was upgraded to D from D- on 3/29/2016 due to an increase in the valuation index, total return index and volatility index.
D
Sell
3/14/2016Downgrade
Nephros, Inc. (NEPH) was downgraded to D- from D on 3/14/2016 due to a decline in the valuation index.
Nephros, Inc. (NEPH) was downgraded to D- from D on 3/14/2016 due to a decline in the valuation index.
D
Sell
3/11/2016Downgrade
Nephros, Inc. (NEPH) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index.
Nephros, Inc. (NEPH) was downgraded to D from D+ on 3/11/2016 due to a substantial decline in the volatility index, total return index and growth index.
D
Sell
11/11/2015Downgrade
Nephros, Inc. (NEPH) was downgraded to D+ from C on 11/11/2015 due to a significant decline in the efficiency index, volatility index and valuation index. Total capital declined 147.09% from -$5.93M to $2.79M, and net income declined 67.99% from -$1.82M to -$581.
Nephros, Inc. (NEPH) was downgraded to D+ from C on 11/11/2015 due to a significant decline in the efficiency index, volatility index and valuation index. Total capital declined 147.09% from -$5.93M to $2.79M, and net income declined 67.99% from -$1.82M to -$581.
C
Hold
8/12/2015Upgraded
Nephros, Inc. (NEPH) was upgraded to C from C- on 8/12/2015 due to a significant increase in the efficiency index and solvency index. The quick ratio increased from 0.56 to 0.98, and total capital increased 9.57% from -$5.41M to -$5.93M.
Nephros, Inc. (NEPH) was upgraded to C from C- on 8/12/2015 due to a significant increase in the efficiency index and solvency index. The quick ratio increased from 0.56 to 0.98, and total capital increased 9.57% from -$5.41M to -$5.93M.
C
Hold
8/3/2015Upgraded
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 8/3/2015 due to a large increase in the volatility index and valuation index.
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 8/3/2015 due to a large increase in the volatility index and valuation index.
D
Sell
5/26/2015Downgrade
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 5/26/2015 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 104.63% from -$5.25M to $243, and total capital declined 4.75% from -$5.68M to -$5.41M.
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 5/26/2015 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 104.63% from -$5.25M to $243, and total capital declined 4.75% from -$5.68M to -$5.41M.
C
Hold
5/18/2015Downgrade
Nephros, Inc. (NEPH) was downgraded to C- from C on 5/18/2015 due to a decline in the total return index.
Nephros, Inc. (NEPH) was downgraded to C- from C on 5/18/2015 due to a decline in the total return index.
C
Hold
5/1/2015Upgraded
Nephros, Inc. (NEPH) was upgraded to C from C- on 5/1/2015 due to an increase in the total return index.
Nephros, Inc. (NEPH) was upgraded to C from C- on 5/1/2015 due to an increase in the total return index.
C
Hold
4/24/2015Upgraded
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 4/24/2015 due to a significant increase in the efficiency index, total return index and solvency index. Net income increased 643.77% from -$706 to -$5.25M, the quick ratio increased from 0.4 to 1.12, and debt to equity declined from -4.16 to 0.
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 4/24/2015 due to a significant increase in the efficiency index, total return index and solvency index. Net income increased 643.77% from -$706 to -$5.25M, the quick ratio increased from 0.4 to 1.12, and debt to equity declined from -4.16 to 0.
D
Sell
12/1/2014Downgrade
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 12/1/2014 due to a significant decline in the volatility index.
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 12/1/2014 due to a significant decline in the volatility index.
C
Hold
11/14/2014Upgraded
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 11/14/2014 due to an increase in the volatility index and valuation index.
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 11/14/2014 due to an increase in the volatility index and valuation index.
D
Sell
8/11/2014Downgrade
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 8/11/2014 due to a decline in the total return index.
Nephros, Inc. (NEPH) was downgraded to D+ from C- on 8/11/2014 due to a decline in the total return index.
C
Hold
7/15/2014Upgraded
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 7/15/2014 due to a substantial increase in the volatility index and total return index.
Nephros, Inc. (NEPH) was upgraded to C- from D+ on 7/15/2014 due to a substantial increase in the volatility index and total return index.
D
Sell
5/16/2014Upgraded
Nephros, Inc. (NEPH) was upgraded to D+ from D on 5/16/2014 due to a significant increase in the growth index, valuation index and solvency index. Total revenue increased 109.29% from $226 to $473, the quick ratio increased from 0.2 to 0.41, and debt to equity declined from -2.23 to 0.
Nephros, Inc. (NEPH) was upgraded to D+ from D on 5/16/2014 due to a significant increase in the growth index, valuation index and solvency index. Total revenue increased 109.29% from $226 to $473, the quick ratio increased from 0.2 to 0.41, and debt to equity declined from -2.23 to 0.
NASDAQ
03/13/2025 4:00PM Eastern
Quotes delayed
